Quick Ratio

Amicus Therapeutics' current quick ratio of 1.38x means it holds $1.38 in highly liquid assets (cash, marketable securities, receivables) for every $1 of short-term liabilities — a measure of near-term financial health.

At 1.38x, the ratio sits exactly at the 51st percentile among Healthcare peers, slightly above the sector median of 1.33x, indicating the company's liquidity is roughly in line with the typical peer. While a year-over-year change is not available, the latest quarter-over-quarter figure shows a decline of 19.8% from 1.72x to 1.38x, representing a notable drop in liquidity over the prior three months. The combination of a level that is just above the sector median with a sharp downward trend suggests the company’s liquidity buffer is shrinking, which could introduce short-term risk if the decline continues. This mixed picture — an average current standing but a worsening trajectory — supports the overall NEUTRAL verdict, as the metric neither highlights a clear strength nor signals an urgent red flag.

Frequently Asked Questions

Closest Sector Peers